A Different Approach to Preventing Thrombosis

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 329 participants.

Also called NCT02774265

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 329 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02774265
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02774265. Randomized; no masking; primary purpose prevention. Start 2016-01 (actual); primary completion 2017-05 (actual). Results posted on 2018-07-24.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Different Approach to Preventing Thrombosis
Acronym
ADAPT
Condition
Venous Thromboembolism
Intervention (Drug)
VTE prophylaxis with Enoxaparin 30mg BID
Intervention (Drug)
VTE prophylaxis with Aspirin 81mg BID
Lead sponsor
University of Maryland, Baltimore (class: other)

Record details

Record id
cardio:ct-nct02774265
Content hash
2ba690c6c1248de837f263cd15a77f033c558d4b8de1f2f9b3395352d788e931